Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience
- PMID: 25326737
- DOI: 10.1016/j.jcin.2014.05.023
Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experience
Abstract
Objectives: This study compared alcohol septal ablation (ASA) and surgical myectomy for periprocedural complications and long-term clinical outcome in patients with symptomatic hypertrophic obstructive cardiomyopathy.
Background: Debate remains whether ASA is equally effective and safe compared with myectomy.
Methods: All procedures performed between 1981 and 2010 were evaluated for periprocedural complications and long-term clinical outcome. The primary endpoint was all-cause mortality; secondary endpoints consisted of annual cardiac mortality, New York Heart Association functional class, rehospitalization for heart failure, reintervention, cerebrovascular accident, and myocardial infarction.
Results: A total of 161 patients after ASA and 102 patients after myectomy were compared during a maximal follow-up period of 11 years. The periprocedural (30-day) complication frequency after ASA was lower compared with myectomy (14% vs. 27%, p = 0.006), and median duration of in-hospital stay was shorter (5 days [interquartle range (IQR): 4 to 6 days] vs. 9 days [IQR: 6 to 12 days], p < 0.001). After ASA, provoked gradients were higher compared with myectomy (19 [IQR: 10 to 42] vs. 10 [IQR: 7 to 13], p < 0.001). After multivariate analysis, age (per 5 years) (hazard ratio: 1.34 [95% confidence interval: 1.08 to 1.65], p = 0.007) was the only independent predictor for all-cause mortality. Annual cardiac mortality after ASA and myectomy was comparable (0.7% vs. 1.4%, p = 0.15). During follow-up, no significant differences were found in symptomatic status, rehospitalization for heart failure, reintervention, cerebrovascular accident, or myocardial infarction between both groups.
Conclusions: Survival and clinical outcome were good and comparable after ASA and myectomy. More periprocedural complications and longer duration of hospital stay after myectomy were offset by higher gradients after ASA.
Keywords: alcohol septal ablation; hypertrophic obstructive cardiomyopathy; long-term outcome; myectomy.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Myectomy versus alcohol septal ablation: experience remains key.JACC Cardiovasc Interv. 2014 Nov;7(11):1235-6. doi: 10.1016/j.jcin.2014.05.022. Epub 2014 Oct 15. JACC Cardiovasc Interv. 2014. PMID: 25326738 No abstract available.
Similar articles
-
Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry.J Am Heart Assoc. 2017 May 16;6(5):e005735. doi: 10.1161/JAHA.117.005735. J Am Heart Assoc. 2017. PMID: 28512112 Free PMC article.
-
The long-term outcomes of transcoronary ablation of septal hypertrophy compared to surgical myectomy in patients with symptomatic hypertrophic obstructive cardiomyopathy.Catheter Cardiovasc Interv. 2014 Feb;83(2):270-7. doi: 10.1002/ccd.25134. Epub 2013 Aug 31. Catheter Cardiovasc Interv. 2014. PMID: 23873660
-
Continuous rhythm monitoring for ventricular arrhythmias after alcohol septal ablation for hypertrophic cardiomyopathy.Heart. 2014 Dec;100(23):1865-70. doi: 10.1136/heartjnl-2014-305593. Epub 2014 Jul 29. Heart. 2014. PMID: 25073885
-
A meta analysis of current status of alcohol septal ablation and surgical myectomy for obstructive hypertrophic cardiomyopathy.Catheter Cardiovasc Interv. 2016 Jul;88(1):107-15. doi: 10.1002/ccd.26293. Epub 2015 Nov 3. Catheter Cardiovasc Interv. 2016. PMID: 26526299
-
Alcohol septal ablation vs myectomy for symptomatic hypertrophic obstructive cardiomyopathy: Systematic review and meta-analysis.Clin Cardiol. 2019 Jan;42(1):190-197. doi: 10.1002/clc.23113. Epub 2018 Nov 29. Clin Cardiol. 2019. PMID: 30421437 Free PMC article.
Cited by
-
Elevated lymphatic vessel density measured by Lyve-1 expression in areas of replacement fibrosis in the ventricular septum of patients with hypertrophic obstructive cardiomyopathy (HOCM).Heart Vessels. 2020 Jan;35(1):78-85. doi: 10.1007/s00380-019-01463-5. Epub 2019 Jun 27. Heart Vessels. 2020. PMID: 31250132
-
Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry.J Am Heart Assoc. 2017 May 16;6(5):e005735. doi: 10.1161/JAHA.117.005735. J Am Heart Assoc. 2017. PMID: 28512112 Free PMC article.
-
Unexpected complication of septal ablation 22 years later, septal diverticule with thrombus.Anatol J Cardiol. 2021 Nov;25(11):832-833. doi: 10.5152/AnatolJCardiol.2021.56. Anatol J Cardiol. 2021. PMID: 34734818 Free PMC article. No abstract available.
-
Muscular Mitral Chord Contribution to Left Ventricular Outflow Tract Obstruction in HOCM.Thorac Cardiovasc Surg Rep. 2019 Jan;8(1):e18-e19. doi: 10.1055/s-0039-1692155. Epub 2019 Jun 16. Thorac Cardiovasc Surg Rep. 2019. PMID: 31211027 Free PMC article.
-
Transcatheter septal ablation in hypertrophic obstructive cardiomyopathy: a technical guide and review of published results.Heart Fail Rev. 2018 Nov;23(6):907-917. doi: 10.1007/s10741-018-9706-z. Heart Fail Rev. 2018. PMID: 29736811 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical